Jubilee celebration of first kidney transplant in NSW, Australia.
In August of 2015 I had the pleasure of being a guest speaker at the 50th Anniversary of Kidney Transplantation in New South Wales, Australia. This first kidney transplant operation was performed 50 years ago at Prince Henry Hospital by a team led by Professor Joe Murnaghan (a urologist) and Dr Doug Tracy (a vascular […]
Read moreWorld Transplant Congress
The World Congress in Transplantation, which was a joint meeting between the TTS, the ASTS and the AST took place in San Francisco from the 26th to the 31st of July. It was a huge meeting with some 7,000 people attending which made it quite difficult to meet people. The opening ceremony was rather special […]
Read moreWTC 2014: Neonatal donor kidneys
Dr Richard Perez presented a fascinating abstract on the use of of neonatal donor kidneys. The mean donor age was 20 days and 70% of kidneys came from DCD donors. Twenty recipients with a mean weight of 54 kg received infant kidneys. There has been no deaths but 4 early graft failures. The surgical complications […]
Read moreCET poster abstracts received distinction awards at the WTC 2014
Great success for the CET at the World Transplant Congress: all 4 poster abstracts that were presented at the WTC received distinction awards. These were: * A comparison of University of Wisconsin and Marshall’s solutions for cold storage of deceased donor kidneys in the United Kingdom. * What is the evidence for oxygenated hypothermic machine […]
Read moreHypothermic organ preservation studies presented at the World Transplant Congress 2014
There were several presentations at the recent World Transplant Congress in San Francisco that discussed the latest developments in hypothermic organ preservation techniques. Using the Scientific Registry of Transplant Recipients, Gill et al of the Vancouver group examined the impact of Hypothermic Machine Perfusion (HMP) on the risk of DGF depending on the Kidney Donor Profile […]
Read moreDonor specific HLA alloantibodies (DSA) in liver transplantation
A conference was held with an invited faculty (predominantly from the USA) and sponsored by industry to discuss the impact of DSA in liver transplantation and this article reports their opinions. It was agreed that the presence of DSA are recognised now to have a deleterious effect on outcome, particularly if HLA Class II antibodies, […]
Read moreWhat trials in transplantation would you like to see?
Peter Morris gave the following presentation at this year’s British Transplant Society Congress after polling members as to what trials they would like to see performed in the field of transplantation in the near future. There are many interesting ideas to help guide future research projects. If you have any further ideas, please let us […]
Read moreCET meeting in Oxford
On the 20th September we had our regular meeting in the Richard Doll Building in Oxford. It was a very good day in that John O’Callaghan reviewed his current work on a systematic review of liver preservation solutions together with a multivariate analysis of 4,500 kidney transplants from the NHSBT registry. Robin Som reviewed his […]
Read moreKidney Preservation (TTS Congress, Berlin July 2012)
I was greatly impressed with the Transplantation Society Congress in Berlin last month. The venues and organisation were first class. There were also many high level presentations and discussions that have both informed and stimulated interested minds. Given my own interests, a personal highlight was the session on Organ Procurement and Preservation, where much good […]
Read moreIndustry sponsored symposia
There were a number of corporate symposia at the ESOT Congress, which is accepted practice these days at most large meetings. However I did hear a lot of criticism about the biased presentations made at some of these symposia, which I had not heard before! Certainly I went to one sponsored by Astellas which was […]
Read more